Content

CRO News

American Diversified Holdings’ GlucoGuard Retains Global CRO for FDA-Required Patient Study

2 April 2026

CDMO News

Anixa Biosciences Signs CDMO Deal with Cytovance for Phase 2 Breast Cancer Vaccine

2 April 2026

CDMO News

ROIS CDMO Completes U.S. Injectable Facility Acquisition in Arizona

2 April 2026

CDMO News

Neuland Laboratories Appoints Saharsh Davuluri as CEO

2 April 2026

CRO News

Lexaria Bioscience Signs CRO Contracts for New GLP-1 Human Study

2 April 2026

CDMO News

Ardena Supports CYRS1542 Progression into Phase 1 Clinical Development

1 April 2026

CDMO News

Symbiosis Pharmaceutical Services Expands QC Lab with New 30°C Stability Chamber

1 April 2026

Expert Insight

Peptide Synthesis Strategy for Late-Stage Development: What Biotech and Pharma Buyers Need to Know

1 April 2026

CDMO News

Adragos Pharma Acquires Sanofi’s Maisons-Alfort Sterile Fill-Finish Facility in France

1 April 2026

CRO News

Lunit Expands CRO Partnership With CellCarta to Advance AI Biomarker Development

1 April 2026